NO20013013D0 - <Alpha> v <beta> 6-integrin - Google Patents

<Alpha> v <beta> 6-integrin

Info

Publication number: NO20013013D0
Authority: NO; Norway
Prior art keywords: integrin; beta; alpha
Prior art date: 1998-12-19

Application number

NO20013013A

Other languages

Norwegian (no)

Other versions

NO20013013L (en

Inventor

Beate Diefenbach

Alfred Jonczyk

Sabine Kraft

Ray Mehta

Original Assignee

Merck Patent Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-12-19

Filing date

2001-06-18

Publication date

2001-06-18

2001-06-18 Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh

2001-06-18 Publication of NO20013013L publication Critical patent/NO20013013L/en

2001-06-18 Publication of NO20013013D0 publication Critical patent/NO20013013D0/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Physical Education & Sports Medicine (AREA)
Diabetes (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Ophthalmology & Optometry (AREA)
Immunology (AREA)
Genetics & Genomics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Urology & Nephrology (AREA)
Heart & Thoracic Surgery (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Dermatology (AREA)
Hematology (AREA)
Cardiology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Obesity (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Vascular Medicine (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20013013A 1998-12-19 2001-06-18 <Alpha> v <beta> 6-integrin NO20013013D0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19858857		1998-12-19
PCT/EP1999/009842 WO2000037487A1 (en)	1998-12-19	1999-12-11	αvβ6 INTEGRIN INHIBITORS

Publications (2)

Publication Number	Publication Date
NO20013013L NO20013013L (en)	2001-06-18
NO20013013D0 true NO20013013D0 (en)	2001-06-18

Family

ID=7891834

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20013013A NO20013013D0 (en)	1998-12-19	2001-06-18	<Alpha> v <beta> 6-integrin

Country Status (10)

Country	Link
EP (1)	EP1140989A1 (en)
JP (1)	JP2002533064A (en)
CN (1)	CN1335853A (en)
AR (1)	AR022395A1 (en)
BR (1)	BR9916323A (en)
CA (1)	CA2355874A1 (en)
CZ (1)	CZ20012212A3 (en)
NO (1)	NO20013013D0 (en)
WO (1)	WO2000037487A1 (en)
ZA (1)	ZA200105929B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19929410A1 (en) *	1999-06-26	2000-12-28	Merck Patent Gmbh	New octapepide compounds as alpha v beta 6 integrin inhibitors useful for treating and diagnosing heart disease, tumors, osteoporosis, fibrosis, inflammation, infection and psoriasis
DE19933173A1 (en) *	1999-07-15	2001-01-18	Merck Patent Gmbh	Cyclic peptide derivatives as inhibitors of the integrin alpha¶v¶beta¶6¶
KR101098109B1 (en)	2002-03-13	2011-12-26	더 리전츠 오브 더 유니버시티 오브 캘리포니아	ANTI αVβ6 ANTIBODIES
US20090028853A1 (en) *	2006-10-19	2009-01-29	The Regents Of The University Of California, A California Corporation	TREATMENT AND PREVENTION OF CHRONIC ASTHMA USING ANTAGONISTS OF INTEGRIN ALPHAvBETA6
PL377560A1 (en) *	2003-02-06	2006-02-06	Merck Patent Gmbh	Peptidic sulfonamides
CN104072614B (en)	2005-07-08	2017-04-26	生物基因Ma公司	Anti-alpha[v]beta[6] antibodies and uses thereof
GB0520068D0 (en)	2005-10-03	2005-11-09	Cancer Res Technology	av peptide ligand
AU2007272995B2 (en)	2006-07-10	2013-02-07	Biogen Idec Ma Inc.	Compositions and methods for inhibiting growth of smad4-deficient cancers
TW200815474A (en)	2006-08-03	2008-04-01	Astrazeneca Ab	Antibodies alphaVbeta6 and uses thereof
WO2009093251A2 (en) *	2008-01-24	2009-07-30	Gavish-Galilee Bio Applications Ltd	Reovirus vaccine based on sigma c protein sequence
EP2870170B1 (en) *	2012-07-03	2017-09-06	Il Yang Pharm. Co., Ltd.	Novel peptides and use thereof
WO2014143739A2 (en)	2013-03-15	2014-09-18	Biogen Idec Ma Inc.	Anti-alpha v beta 6 antibodies and uses thereof
US10035859B2 (en)	2013-03-15	2018-07-31	Biogen Ma Inc.	Anti-alpha V beta 6 antibodies and uses thereof
CA3054792A1 (en)	2017-02-28	2018-09-07	Morphic Therapeutic, Inc.	Inhibitors of .alpha.v.beta.6 integrin
US20180244648A1 (en)	2017-02-28	2018-08-30	Lazuli, Inc.	Inhibitors of (alpha-v)(beta-6) integrin
CR20210109A (en)	2018-08-29	2021-06-24	Morphic Therapeutic Inc	INHIBITING av ß6 INTEGRIN

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ219515A (en) *	1987-02-10	1989-09-27	Wellcome Found	Fusion proteins comprising influenza virus ha and a nonnatural antigenic epitope

1999
- 1999-12-11 JP JP2000589556A patent/JP2002533064A/en active Pending
- 1999-12-11 CA CA002355874A patent/CA2355874A1/en not_active Abandoned
- 1999-12-11 BR BR9916323-3A patent/BR9916323A/en not_active IP Right Cessation
- 1999-12-11 WO PCT/EP1999/009842 patent/WO2000037487A1/en not_active Application Discontinuation
- 1999-12-11 CZ CZ20012212A patent/CZ20012212A3/en unknown
- 1999-12-11 EP EP99963507A patent/EP1140989A1/en not_active Withdrawn
- 1999-12-11 CN CN99814760A patent/CN1335853A/en active Pending
- 1999-12-17 AR ARP990106525A patent/AR022395A1/en not_active Application Discontinuation
2001
- 2001-06-18 NO NO20013013A patent/NO20013013D0/en not_active Application Discontinuation
- 2001-07-18 ZA ZA200105929A patent/ZA200105929B/en unknown

Also Published As

Publication number	Publication date
CA2355874A1 (en)	2000-06-29
CN1335853A (en)	2002-02-13
WO2000037487A1 (en)	2000-06-29
AR022395A1 (en)	2002-09-04
CZ20012212A3 (en)	2001-09-12
EP1140989A1 (en)	2001-10-10
NO20013013L (en)	2001-06-18
WO2000037487A8 (en)	2001-03-29
BR9916323A (en)	2001-10-30
ZA200105929B (en)	2003-03-18
JP2002533064A (en)	2002-10-08

Publication	Publication Date	Title
NO20006268D0 (en)	2000-12-11	<Beta> karbolinforbindelser
ID25977A (en)	2000-11-16	DIAPON ONCE USE
ID24555A (en)	2000-07-27	DIAPON ONCE USE
ID23076A (en)	2000-02-03	DIAPON ONCE USE
NO20005337L (en)	2000-12-28	Polyol-IFN- <BETA> conjugates
DE69827672D1 (en)	2004-12-23	TELESCOPIC-LIKE INTRAORAL ELEMENT
IS5699A (en)	2000-11-01	New use
ID26162A (en)	2000-11-30	BENZILBIFENIL BIOSIDA DESIGNS
ID23287A (en)	2000-04-05	SUBSTITUTED TRISICLIC
NO992667D0 (en)	1999-06-02	Human <beta> 2-integrin <alfa> subunit
ID23083A (en)	2000-02-03	DIAPON ONCE USE
DE69902762D1 (en)	2002-10-10	RISER-SPAN ARRANGEMENT
NO20013013L (en)	2001-06-18	<Alpha> v <beta> 6-integrin
DE59901977D1 (en)	2002-08-08	Analog-to-digital converter
NO971248D0 (en)	1997-03-18	5 <alpha> -reduktaseinhibitorer
ID23219A (en)	2000-03-30	SUBSTITUTED TRISICLIC
NO20014010D0 (en)	2001-08-17	<Beta> -alaninderivater
NO20020885D0 (en)	2002-02-22	<Alpha> v <beta> 3-integrin
FI980759A0 (en)	1998-04-02	Taetningskonstruktion Foer suglaodan i en sugvals
DE59911610D1 (en)	2005-03-17	SUBSTITUTED BENZOYLCYCLOHEXANDIONE
DE59912188D1 (en)	2005-07-21	SUBSTITUTED PHENYLURACILE
DE59912532D1 (en)	2005-10-13	SUBSTITUTED ACYLAMINOPHENYL-URACILE
PT1076660E (en)	2002-11-29	(4-BROMOPYRAZOL-3-YL) -BZZAZOLES
NO980270D0 (en)	1998-01-21	Trekka scheme
NO20010280L (en)	2001-03-08	<Alfa> -aminosyrefenylesterderivater

Legal Events

Date	Code	Title	Description
2005-09-12	FC2A	Withdrawal, rejection or dismissal of laid open patent application